Stryker (SYK) Interest Expenses (2025 - 2026)

Stryker (SYK) reported Interest Expenses of $148.0 million for Q1 2026, up 8.03% year-over-year from $137.0 million in Q1 2025, and up 8.03% quarter-over-quarter from $137.0 million in Q1 2025.

Stryker (SYK) Interest Expenses (2025 - 2026) Analysis & Trends

Stryker (SYK) has 2 years of Interest Expenses data on file, last reported at $148.0 million in Q1 2026.

  • Interest Expenses for Q1 2026 came in at $148.0 million, up 8.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $148.0 million (up 8.03% YoY), and the FY2025 annual result was $607.0 million, up 48.41% from the prior year.
  • Interest Expenses rose to $148.0 million in Q1 2026 per SYK's latest filing, from $137.0 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $148.0 million in Q1 2026 and troughed at $137.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 174.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 148.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 181.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 90.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -97.17 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 96.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 15.10 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 148.00 Mn
Mar 31, 2026 148.00 Mn
Mar 31, 2025 137.00 Mn
Mar 31, 2025 137.00 Mn